(Press-News.org) CHICAGO – The addition of a screening ultrasound or magnetic resonance imaging (MRI) to annual mammography in women with an increased risk of breast cancer and dense breast tissue resulted in a higher rate of detection of incident breast cancers, according to a study in the April 4 issue of JAMA.
"Annual ultrasound screening may detect small, node-negative breast cancers that are not seen on mammography. Magnetic resonance imaging may reveal additional breast cancers missed by both mammography and ultrasound screening," according to background information in the article.
Wendie A. Berg, M.D., Ph.D., formerly of the American College of Radiology Imaging Network, Philadelphia, and colleagues conducted a study to determine the supplemental cancer detection yield of ultrasound and MRI in women at elevated risk for breast cancer. The study included 2,809 women (with increased cancer risk and dense breasts) at 21 sites who consented to 3 annual independent screens with mammography and ultrasound in randomized order. Median age at enrollment was 55 years. Nearly 54 percent of women had a personal history of breast cancer. After 3 rounds of both screenings, 612 of 703 women who chose to undergo an MRI had complete data.
A total of 2,662 women underwent 7,473 mammogram and ultrasound screenings, 110 of whom had 111 breast cancer events. Fifty-nine cancers (53 percent) were detected by mammography, including 33 (30 percent) that were detected by mammography only; 32 (29 percent) by ultrasound only; and 9 (8 percent) by MRI only after both mammography and ultrasound screens failed to detect cancer. Eleven cancers (10 percent) were not detected by any imaging screen. A total of 16 of 612 women (2.6 percent) in the MRI substudy were diagnosed with breast cancer.
Among 4,814 incidence screens in the second and third years combined, 75 women were diagnosed with cancer. The researchers found that supplemental ultrasound increased cancer detection with each annual screen beyond that of mammography, adding detection of 5.3 cancers per 1,000 women in the first year; 3.7 women per 1,000 per year in each of the second and third years; and averaging 4.3 per 1,000 for each of the 3 rounds of annual screening. The addition of MRI screening further increased cancer detection with a supplemental cancer detection yield of 14.7 per 1,000 women. The number of screens needed to detect 1 cancer was 127 for mammography; 234 for supplemental ultrasound, and 68 for supplemental MRI after negative mammography plus ultrasound screening results.
"Despite its higher sensitivity, the addition of screening MRI rather than ultrasound to mammography in broader populations of women at intermediate risk with dense breasts may not be appropriate, particularly when the current high false-positive rates, cost, and reduced tolerability of MRI are considered," the authors conclude.
###
(JAMA. 2012;307[13]:1394-1404. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Dr. Berg is now with Magee-Womens Hospital, University of Pittsburgh School of Medicine. The study was funded by the Avon Foundation and grants from the National Cancer Institute. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, etc.
Please Note: For this study, there will be multimedia content available, including the JAMA Report video, embedded and downloadable video, audio files, text, documents, and related links. This content will be available at 3 p.m. CT Tuesday, April 3 at this link.
To contact Wendie A. Berg, M.D., Ph.D., call Shawn Farley at 703-648-8936 or email sfarley@acr.org.
END
CHICAGO – Although data indicate that between 2003-2009 there was a substantial decline in the U.S. in hospitalizations for pneumonia and inpatient deaths, analysis suggests that trends in documentation and diagnostic coding, rather than improvements in actual outcomes, may explain much of the observed changes, according to a study in the April 4 issue of JAMA.
Pneumonia is a leading cause of illness and death among U.S. adults, resulting in more than 1 million annual hospital admissions and accounting for more than $10.5 billion in aggregate costs. "Given its public ...
CHICAGO – Adding the drug cetuximab to a regimen of drugs used for the treatment of patients following surgery for stage III colon cancer did not result in improved disease-free survival, according to a study in the April 4 issue of JAMA.
Patients who have surgery for removal of stage III colon cancer have a 50 percent chance of cure. Multiple trials have established the benefit of chemotherapy after surgery in reducing the recurrence risk. "Specifically, [the drugs] leucovorin, fluorouracil, and oxaliplatin (FOLFOX or slightly different method, FLOX) provides significant ...
CHICAGO – In an analysis of a cohort that included nearly one million patients who had visited an ophthalmologist, patients who were taking oral fluoroquinolones had a higher risk of developing a retinal detachment, a serious eye condition, compared with nonusers, although the absolute risk was small, according to a study in the April 4 issue of JAMA.
"Fluoroquinolones are one of the most commonly prescribed classes of antibiotics. Their broad-spectrum antibacterial coverage and high-tissue distribution provide potency for a wide variety of community-acquired infections," ...
CHICAGO --The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
The findings were announced during the American Association for Cancer Research (AACR) Annual Meeting 2012, March 31-April 4, in Chicago.
"The most important finding is that this approach is feasible and we are encouraged by preliminary evidence that this approach may ...
Johns Hopkins investigators are testing a way to use drugs that target a cholesterol pathway to enhance the cancer-killing potential of standard chemotherapy drugs. Their tests, in mouse models of pancreatic cancer, may yield new and more effective combinations of current and possibly new anti-cancer drugs.
Besides their deadly consequences, pancreatic cancer and heart disease share a connection with genetic pathways that control cholesterol and a cell signaling system known as the Hedgehog pathway. (The name refers to the shape of its mutated protein in fruit flies, ...
In a research article published April 3 in the online, open-access journal PLoS Biology, Prof. Sylvia Cremer and colleagues at the Institute of Science and Technology, Austria show how micro-infections promote social vaccination in ant societies. Like crowded megacities, ant colonies face a high risk of disease outbreaks. These are kept in check by the ants' social immune system—a set of collective hygienic behaviours and adaptive changes in interaction frequencies that acts in conjunction with the physiological, innate immune system of colony members. Prof. Cremer and ...
Top executives at Anago Cleaning Systems hosted its 2012 annual conference for their Master Franchisees in an effort to celebrate major growth and successes in 2011, and prepare for aggressive expansion and improvement throughout each territory and the nation. New and existing Master Franchisees alike attended the two-day show that was held on March 5-6, 2012 in Orlando, Florida.
The convention kicked off with opening remarks from Anago Cleaning Systems Founder, David Povlitz.
Mr. Povlitz reiterated that the vision, mission, and values of the company he founded in ...
An international team of scientists has created an innovative tool for teaching the fundamentals of epidemiology—the science of how infectious diseases move through a population.
The team teaches a workshop annually in South Africa that helps epidemiologists improve the mathematical models they use to study outbreaks of diseases like cholera, AIDS and malaria. Led by Steve Bellan from the University of California at Berkeley, the team created a new game as a teaching aid for the workshop. The exercise, which has proven extremely effective in demonstrating concepts in ...
Genetic mutations in cancer cells can lead to resistance to treatment, thereby potentially resulting in relapse. However, a new article, published April 3 in the magazine section of the online, open-access journal PLoS Biology, suggests that the converse may also happen. Steven Frank from the University of California, Irvine, and Marsha Rosner from the University of Chicago, propose that it may often be the case that a few cells become resistant before any genetic change, and then later acquire the genes to stabilize that resistance.
Why does it matter whether resistance ...
CAL Business Solutions, a Connecticut based Microsoft Dynamics GP partner, today announced that it will host the first ever New England SalesPad user group workshop. Companies using Microsoft Dynamics GP with SalesPad, an add on product for the distribution industry, will have the opportunity to come together to see new features, share ideas, network with their peers and provide input on future product developments.
The user group will be held at the Crowne Plaza hotel in Cromwell, Connecticut from 8:00-11:30am on Monday May 7th. Topics on the agenda include advanced ...
